PSTV- Plus Therapeutics, Inc.

Name: Plus Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Plus Therapeutics, Inc. (PSTV) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. PSTV is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Hawkins Richard J	397.8K	$2.43M	-
CEO	Hedrick Marc H	339.8K	$2.08M	-
Dir	Van Es-Johansson An	297.8K	$1.82M	-
Dir	Clowes Howard	297.8K	$1.82M	-
Dir	Guse Kyle	297.8K	$1.82M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 26, 2022	Hedrick Marc H	Chief Executive Officer	Buy	5,000	$0.69	$3,450.00	+23.7%	-21.5%	-66.7%
Mar 1, 2022	Sims Andrew John Hugh MacIntyre	Chief Financial Officer	Buy	2,000	$1.10	$2,199.80	+27.7%	-49.1%	-70.9%
Nov 2, 2021	Sims Andrew John Hugh MacIntyre	Chief Financial Officer	Buy	1,000	$1.86	$1,864.30	+16.1%	-49.8%	-76.6%
Oct 27, 2021	Petersen Greg	Director	Buy	12,500	$1.72	$21,500.00	+62.5%	-49.4%	-71.9%
Oct 26, 2021	Hedrick Marc H	Chief Executive Officer	Buy	2,500	$1.66	$4,149.75	+13.5%	-48.8%	-73.7%
Oct 26, 2021	Sims Andrew John Hugh MacIntyre	Chief Financial Officer	Buy	2,000	$1.67	$3,338.80	+47.3%	-48.8%	-73.7%
Sep 13, 2021	Lenk Robert P50	Director	Buy	7,000	$1.86	$13,010.90	+233.3%	-33.9%	-65.7%
Jul 28, 2021	Sims Andrew John Hugh MacIntyre	Chief Financial Officer	Buy	4,230	$1.98	$8,357.12	+213.0%	-13.8%	-74.2%
Apr 30, 2021	Hedrick Marc H	Chief Executive Officer	Buy	2,183	$2.28	$4,970.04	+13.3%	-14.5%	-70.6%
Mar 4, 2021	Hedrick Marc H	Chief Executive Officer	Buy	2,500	$2.50	$6,250.00	+18.0%	-	-

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC